CoChat

The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women.

Mezquita-Raya, Pedro, de la Higuera, Magdalena, García, Diego Fernández, Alonso, Guillermo, Ruiz-Requena, María Estrella, de Dios Luna, Juan, Escobar-Jiménez, Fernando, Muñoz-Torres, Manuel · 2005 · Osteoporosis International

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Regulation of osteoclastic activity is critical for understanding bone loss associated with the postmenopausal period. In vitro and animal studies have revealed the role of OPG as a decoy receptor that neutralizes the effect of RANKL on the differentiation and activation of osteoclasts. However, the role of the OPG-RANKL system in postmenopausal osteoporosis is controversial. Thus, the aim of this study was to investigate the relationship among circulating levels of OPG, RANKL, bone turnover markers (BTM), bone mineral density (BMD) and vertebral fractures in postmenopausal women. We determined anthropometric parameters, circulating OPG and RANKL, BTM, estradiol, BMD by dual X-ray absorptiometry at the lumbar spine (LS) and femoral neck (FN), and pre-existing vertebral fractures in 206 ambulatory postmenopausal women of a mean age of 62 years (SD 7). Circulating OPG was significantly related to age (r =0.158; P =0.023), years since menopause (r =0.167; P =0.016) and BMD (LS Z-score: r =0.240; P =0.001, FN Z-score: r =0.156; P =0.025). Over half of the women had undetectable RANKL (n =113; 54.9%). There were no significant differences in clinical variables, BTM or BMD among women with detectable vs. undetectable RANKL. OPG was found to be independently associated with osteoporosis (OR: 2.9, 1.4-5.9) and prevalent vertebral fractures (OR: 2.5, 1.2-5.4). We conclude that serum OPG levels are independently associated with bone mass and prevalent vertebral fractures in postmenopausal women.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00198-005-1844-1

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 31 references

Cited by

See all 98

Metadata

Authors
Mezquita-Raya, P., de la Higuera, M., García, D. F., Alonso, G., Ruiz-Requena, M. E., de Dios Luna, J., Escobar-Jiménez, F., & Muñoz-Torres, M.
Affiliations
  • Universidad de Granada (ES)
  • University Hospital Zurich (CH)
Venue
Osteoporosis International
Published
2005-02-12
Volume
16
Issue
11
Pages
1368-1374
ISSN
  • 0937-941X (ISSN-L)
  • 1433-2965
OpenAlex
W2146240002
Cited by
98
References
31
Citations by year
2025: 1 · 2024: 3 · 2022: 5 · 2021: 1 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 5 · 2012: 6
FWCI
8.38
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Osteoporosis International (publishedVersion)
  • PubMed (publishedVersion)
Funders
Eli Lilly and Company
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
osteoprotegerin, RANKL, postmenopausal osteoporosis, vertebral fractures, bone mineral density, bone turnover markers, osteoclast activity, menopause, serum biomarkers, postmenopausal women
MeSH terms
Tartrate-Resistant Acid Phosphatase, Acid Phosphatase, Aged, Alkaline Phosphatase, Carrier Proteins, Estradiol, Female, Femur Neck, Glycoproteins, Humans, Isoenzymes, Lumbar Vertebrae, Membrane Glycoproteins, Middle Aged, Prospective Studies, Biomarkers, Absorptiometry, Photon, Bone Density, Osteoporosis, Postmenopausal, Spinal Fractures, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. https://app.cochat.ai/papers/10.1007/s00198-005-1844-1
The paper
Mezquita-Raya, P., de la Higuera, M., García, D. F., Alonso, G., Ruiz-Requena, M. E., de Dios Luna, J., Escobar-Jiménez, F., & Muñoz-Torres, M. (2005). The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. Osteoporosis International. https://doi.org/10.1007/s00198-005-1844-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.